Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

Comparative efficacy of delafloxacin for complicated and acute bacterial skin and skin structure infections: results from a network meta-analysis

Abstract Background Delafloxacin is a novel fluoroquinolone with broad antibacterial activity against pathogens causing acute bacterial skin and skin structure infections (ABSSSI). This network meta-analysis (NMA) was conducted to evaluate the relative efficacy of delafloxacin versus other comparato...

Full description

Bibliographic Details
Main Authors:	Ioanna Vlachaki, Matteo Vacchelli, Daniela Zinzi, Edel Falla, Yilin Jiang, Theo Mantopoulos, Dilip Nathwani
Format:	Article
Language:	English
Published:	BMC 2021-10-01
Series:	BMC Infectious Diseases
Subjects:	Acute bacterial skin and skin structure infections Methicillin-resistant Staphylococcus aureus Delafloxacin Network meta-analysis
Online Access:	https://doi.org/10.1186/s12879-021-06736-x

Similar Items

Emerging treatment options for acute bacterial skin and skin structure infections: focus on intravenous delafloxacin
by: Righi E, et al.
Published: (2018-04-01)

Delafloxacin: design, development and potential place in therapy
by: Candel FJ, et al.
Published: (2017-03-01)

Efficacy and safety of delafloxacin in the treatment of acute bacterial skin and skin structure infections: a systematic review and meta-analysis of randomized controlled trials
by: Lan SH, et al.
Published: (2019-05-01)

A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections
by: William O’Riordan, et al.
Published: (2015-01-01)

The efficacy and adverse events of delafloxacin for treating acute bacterial skin and skin structure infections: A systematic review and meta-analysis
by: Syed Bilal Tanvir, et al.
Published: (2020-01-01)

Update on the activity of delafloxacin against acute bacterial skin and skin-structure infection isolates from European hospitals (2014–2019)
by: Dee Shortridge, et al.
Published: (2020-12-01)

A Case Report of Staphylococcal Scalded Skin Syndrome with Toxic Shock Syndrome
by: Vaishali Kathuria, et al.
Published: (2020-04-01)

Anti-MRSA Cephalosporin versus Vancomycin-Based Treatment for Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Ching-Yi Chen, et al.
Published: (2021-08-01)

Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections
by: Larissa S. May, et al.
Published: (2015-10-01)

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus
by: Kimberly C. Claeys, et al.
Published: (2019-03-01)

Ceftaroline Efficacy and Safety in Treatment of Complicated Skin and Soft Tissue Infection: A Systemic Review and Meta-Analysis of Randomized Controlled Trials
by: Shao-Huan Lan, et al.
Published: (2019-05-01)

Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial
by: Sandra McCurdy, et al.
Published: (2020-08-01)

Skin Infections Caused by Staphylococcus aureus
by: Pascal Del Giudice
Published: (2020-04-01)

Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics
by: Leong HN, et al.
Published: (2018-10-01)

Methicillin-resistant Staphylococcus aureus in Community-acquired Skin Infections
by: Gregory J. Moran, et al.
Published: (2005-06-01)

A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections
by: Grace C. Lee, et al.
Published: (2016-11-01)

Human skin microbiota-friendly lysostaphin
by: Bereznicka, A., et al.
Published: (2021)

Diagnostic Stewardship: A Clinical Decision Rule for Blood Cultures in Community-Onset Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections
by: Sarah C. J. Jorgensen, et al.
Published: (2019-02-01)

New Antibiotics for the Treatment of Acute Bacterial Skin and Soft Tissue Infections in Pediatrics
by: Nicola Principi, et al.
Published: (2020-10-01)

Treatment of acute bacterial skin and skin structure infection with single-dose dalbavancin in persons who inject drugs
by: Pedro Luis Gonzalez, et al.
Published: (2018-12-01)

Methicillin-resistant Staphylococcus aureusmenace: A dermatologist′s perspective
by: Manjunath Hulmani, et al.
Published: (2017-01-01)

Antimicrobial stewardship in patients with acute bacterial skin and skin-structure infections: An international Delphi consensus
by: Alex Soriano, et al.
Published: (2020-09-01)

Characterization of pediatric patients with cellulitis attended to in the province of Mayabeque
by: Mercedes Silva Rojas, et al.
Published: (2016-11-01)

Spectroscopic Studies of Delafloxacin Meglumine
by: Xin-yi ZHAO, et al.
Published: (2021-06-01)

Skin and Soft Tissue Infections Caused by Methicillin-Resistant Staphylococcus aureus USA300 Clone
by: Jennifer K. Johnson, et al.
Published: (2007-08-01)

Trends in US Hospital Admissions for Skin and Soft Tissue Infections
by: John Edelsberg, et al.
Published: (2009-09-01)

Development of Lipomer Nanoparticles for the Enhancement of <i>Drug</i> Release, Anti-Microbial Activity and Bioavailability of Delafloxacin
by: Md. Khalid Anwer, et al.
Published: (2020-03-01)

Oral antibiotics for methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infections (SSTIs) in the primary care setting : incidence of treatment failure and its additional economic impact
by: Labreche, Matthew Jude
Published: (2012)

Potential of the Introduction of Tedizolid for the Treatment of Complicated Skin and Soft Tissue Infections in a Russian Multi-Field Hospital
by: Belkova Yu.А., et al.
Published: (2016-08-01)

Features and associated factors of bacterial skin infections in hospitalized patients with pemphigus: a single-center retrospective study
by: Furong Li, et al.
Published: (2020-10-01)

Staphylococcal Scalded Skin Syndrome in Child. A Case Report and a Review from Literature
by: Grama Alina, et al.
Published: (2016-10-01)

Skin Microbiome in Atopic Dermatitis
by: Sofie M. Edslev, et al.
Published: (2020-06-01)

Staphylococcal scalded skin syndrome in a premature newborn caused by methicillin-resistant Staphylococcus aureus: case report
by: Andreas Hörner, et al.

Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections and minocyclin treatment experience in the dermatological setting of eastern Taiwan
by: Tzu-Chun Lin, et al.
Published: (2011-09-01)

Molecular characteristics of Staphylococcus aureus isolates colonizing human nares and skin
by: Na Zhao, et al.
Published: (2021-03-01)

A Calm, Dispassionate Look at Skin Microbiota in Atopic Dermatitis: An Integrative Literature Review
by: Pengjie Wan, et al.
Published: (2020-01-01)

Staphylococcal scalded skin syndrome in a newborn
by: D Jeyakumari, et al.
Published: (2009-01-01)

Community-acquired methicillin-resistant Staphylococcus aureus carrying SCCmec type IV in southern Brazil
by: Luciane Cristina Gelatti, et al.
Published: (2013-01-01)

by: Luciane Cristina Gelatti, et al.
Published: (2013-01-01)

Staphylococcal Virulence Factors on the Skin of Atopic Dermatitis Patients
by: Mary C. Moran, et al.
Published: (2019-12-01)